Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Compugen Ltd (CGEN)

Compugen Ltd (CGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Compugen: Q3 Earnings Snapshot AP - Tue Nov 12, 8:56AM CST

Compugen: Q3 Earnings Snapshot

CGEN : 1.5900 (-0.62%)
Compugen: Q2 Earnings Snapshot AP - Tue Aug 6, 6:22AM CDT

Compugen: Q2 Earnings Snapshot

CGEN : 1.5900 (-0.62%)
Dollars and Wallets - Holding Money Bunched in Fist
5 Growth Stocks Under $10 to Scoop Up Now Barchart - Tue Jan 23, 2:30PM CST

Investment in penny stocks can be a risky proposition. However, here are 5 stocks that could have major upside potential, according to Wall Street analysts.

CGEN : 1.5900 (-0.62%)
QCOM : 160.42 (-1.83%)
GSAT : 1.7500 (-7.89%)
BITF : 2.27 (-15.80%)
INDI : 4.73 (-0.42%)
KOS : 3.89 (+1.04%)
Compugen to Present at Single Cell Genomics 2023 Meeting PR Newswire - Tue Oct 3, 2023

/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

CGEN : 1.5900 (-0.62%)
Compugen Expands Intellectual Property with New Japanese Patent for the Triple Combination of any Anti-PVRIG, TIGIT and PD-1 Antibody for the Treatment of Cancer PR Newswire - Mon Oct 2, 2023

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

CGEN : 1.5900 (-0.62%)
Compugen to Present at the H.C. Wainwright 25th Annual Global Investment Conference PR Newswire - Thu Aug 31, 2023

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

CGEN : 1.5900 (-0.62%)
Compugen Reports Second Quarter 2023 Results PR Newswire - Mon Aug 7, 2023

Advancing enrollment in two proof-of-concept studies evaluating triple blockade of DNAM-1 axis in patients with microsatellite stable colorectal cancer and...

CGEN : 1.5900 (-0.62%)
Compugen to Release Second Quarter 2023 Results on Monday, August 7, 2023 PR Newswire - Mon Jul 24, 2023

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

CGEN : 1.5900 (-0.62%)
Compugen Wins on PVRIG European Patent Opposition Pursued by GSK and a Third Party PR Newswire - Mon Jul 17, 2023

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

CGEN : 1.5900 (-0.62%)
Compugen Doses First Patient in Triple Immunotherapy Combination COM701, COM902 and Pembrolizumab Platinum Resistant Ovarian Cancer Proof-of-Concept Study PR Newswire - Thu Jun 22, 2023

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

CGEN : 1.5900 (-0.62%)

Barchart Exclusives

Stocks Steady Before the Open With Focus on Key U.S. PPI Data and Powell Speech, Disney Earnings on Tap Barchart - 33 minutes ago
December S&P 500 E-Mini futures (ESZ24) are up +0.14%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.01% this morning as investors awaited crucial U.S. producer inflation data, remarks from Federal Reserve Chair Jerome Powell, and an earnings report from entertainment giant Disney. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot